NO20083760L - New formulations - Google Patents
New formulationsInfo
- Publication number
- NO20083760L NO20083760L NO20083760A NO20083760A NO20083760L NO 20083760 L NO20083760 L NO 20083760L NO 20083760 A NO20083760 A NO 20083760A NO 20083760 A NO20083760 A NO 20083760A NO 20083760 L NO20083760 L NO 20083760L
- Authority
- NO
- Norway
- Prior art keywords
- formulations
- new formulations
- interdose
- fpf
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
Foreliggende oppfinnelse angår nye farmasøytisk aerosol-formuleringer, fremgangsmåter for fremstilling av disse, anvendelse av dem i terapi, doserteinhalatorer som inneholder de nevnte formuleringer, og anvendelse av bioforenlige polymerer for å redusere variasjon av interdose og/eller for å forbedre finpartikkel-fraksjonen (FPF) av de nevnte formuleringer.The present invention relates to novel pharmaceutical aerosol formulations, methods of preparing them, their use in therapy, dosing inhalers containing said formulations, and the use of biocompatible polymers to reduce interdose variation and / or to improve fine particle fraction (FPF). ) of said formulations.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78463406P | 2006-03-22 | 2006-03-22 | |
PCT/US2007/064462 WO2007109698A2 (en) | 2006-03-22 | 2007-03-21 | Novel formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083760L true NO20083760L (en) | 2008-12-17 |
Family
ID=38523271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083760A NO20083760L (en) | 2006-03-22 | 2008-09-01 | New formulations |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2012797A2 (en) |
JP (1) | JP2009530419A (en) |
KR (1) | KR20080110854A (en) |
CN (1) | CN101415428A (en) |
AR (1) | AR060039A1 (en) |
AU (1) | AU2007226899A1 (en) |
BR (1) | BRPI0708798A2 (en) |
CA (1) | CA2646236A1 (en) |
CR (1) | CR10261A (en) |
EA (1) | EA200801854A1 (en) |
IL (1) | IL193723A0 (en) |
MA (1) | MA30328B1 (en) |
MX (1) | MX2008011967A (en) |
NO (1) | NO20083760L (en) |
PE (1) | PE20080124A1 (en) |
TW (1) | TW200803870A (en) |
WO (1) | WO2007109698A2 (en) |
ZA (1) | ZA200807682B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2400950T3 (en) | 2009-02-26 | 2019-07-29 | Glaxo Group Ltd | PHARMACEUTICAL FORMULA comprising 4 - {(1 R) -2 - [(6- {2 - [(2,6-DICHLORBENZYL) OXY] ETHOXY} HEXYL) AMINO] -1-HYDROXYETHYL} -2- (HYDROXYMETHYL) PHENOL |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2122261T3 (en) * | 1993-03-17 | 1998-12-16 | Minnesota Mining & Mfg | AEROSOL FORMULATION CONTAINING A DISPERSION ADJUVANT DERIVED FROM AN ESTER, AMIDA OR MERCAPTOESTER. |
US6750210B2 (en) * | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
AR032471A1 (en) * | 2000-08-05 | 2003-11-12 | Glaxo Group Ltd | DERIVED FROM ANDROSTAN AND SOLVATOS OF THE SAME, ITS USE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PROCESSES TO PREPARE SUCH DERIVATIVES, USEFUL INTERMEDIARIES IN THE PREPARATION OF SUCH DERIVATIVES, PROCESSES TO PREPARE SUCH INTERMEDIATES |
-
2007
- 2007-03-21 EP EP07758963A patent/EP2012797A2/en not_active Withdrawn
- 2007-03-21 EA EA200801854A patent/EA200801854A1/en unknown
- 2007-03-21 WO PCT/US2007/064462 patent/WO2007109698A2/en active Application Filing
- 2007-03-21 CN CNA2007800098351A patent/CN101415428A/en active Pending
- 2007-03-21 AR ARP070101155A patent/AR060039A1/en not_active Application Discontinuation
- 2007-03-21 AU AU2007226899A patent/AU2007226899A1/en not_active Abandoned
- 2007-03-21 MX MX2008011967A patent/MX2008011967A/en not_active Application Discontinuation
- 2007-03-21 PE PE2007000310A patent/PE20080124A1/en not_active Application Discontinuation
- 2007-03-21 CA CA002646236A patent/CA2646236A1/en not_active Abandoned
- 2007-03-21 BR BRPI0708798-5A patent/BRPI0708798A2/en not_active IP Right Cessation
- 2007-03-21 KR KR1020087025825A patent/KR20080110854A/en not_active Application Discontinuation
- 2007-03-21 TW TW096109797A patent/TW200803870A/en unknown
- 2007-03-21 JP JP2009501708A patent/JP2009530419A/en active Pending
-
2008
- 2008-08-27 IL IL193723A patent/IL193723A0/en unknown
- 2008-08-28 CR CR10261A patent/CR10261A/en not_active Application Discontinuation
- 2008-09-01 NO NO20083760A patent/NO20083760L/en not_active Application Discontinuation
- 2008-09-05 ZA ZA200807682A patent/ZA200807682B/en unknown
- 2008-10-07 MA MA31274A patent/MA30328B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20080110854A (en) | 2008-12-19 |
MA30328B1 (en) | 2009-04-01 |
CN101415428A (en) | 2009-04-22 |
JP2009530419A (en) | 2009-08-27 |
ZA200807682B (en) | 2009-11-25 |
MX2008011967A (en) | 2009-01-14 |
CA2646236A1 (en) | 2007-09-27 |
AU2007226899A1 (en) | 2007-09-27 |
PE20080124A1 (en) | 2008-04-21 |
EA200801854A1 (en) | 2009-04-28 |
EP2012797A2 (en) | 2009-01-14 |
WO2007109698A2 (en) | 2007-09-27 |
BRPI0708798A2 (en) | 2011-06-14 |
IL193723A0 (en) | 2009-08-03 |
CR10261A (en) | 2008-11-26 |
WO2007109698A3 (en) | 2008-12-18 |
AR060039A1 (en) | 2008-05-21 |
TW200803870A (en) | 2008-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017502286A1 (en) | Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi) | |
HK1146485A1 (en) | ||
PH12018500640A1 (en) | Optimized monoclonal antibodies agaist tissue factor pathway inhibitor (tfpi) | |
ATE410424T1 (en) | SPIROCYCLIC CYCLOHEXANE DERIVATIVES | |
WO2009135190A3 (en) | Therapeutic calcium phosphate particles and methods of making and using same | |
NO20065936L (en) | Sulfonylethyl phosphorus diamides for use in the treatment of cancer. | |
NO20073059L (en) | 2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | |
MX2009014235A (en) | 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy. | |
WO2007076085A3 (en) | Fused pyrimidones and thiopyrimidones, and uses thereof | |
BR112014008609A2 (en) | pharmaceutical composition, sealed container, metered dose inhaler, method for treating a patient suffering or likely to suffer from a respiratory disorder, and method for manufacturing a pharmaceutical composition | |
UA104988C2 (en) | Novel pyrone-indole derivatives and process for their preparation | |
HK1129376A1 (en) | Novel imidazole derivatives, preparation and user thereof as medicine | |
BR112014027981A2 (en) | fumagilol type compounds and methods of production and use thereof | |
JO3122B1 (en) | Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments | |
UA102238C2 (en) | 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof | |
NO20082047L (en) | Slow release composition, process for its preparation and use thereof | |
NO20092073L (en) | C3A receptor modulators, and methods for their use | |
UY33219A (en) | CYCLIC CETOENOLS FOR THERAPIES | |
FR2977494B1 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACIDS OF DIFFERENT MOLECULAR MASSES | |
MX2015009891A (en) | Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy. | |
NO20083760L (en) | New formulations | |
WO2011113000A8 (en) | Novel ester containing compositions and methods | |
TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
GB0615105D0 (en) | Novel compounds | |
MX2009012712A (en) | Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application | ||
FC2A | Withdrawal, rejection or dismissal of laid open patent application |